Project Number 5U01AG068822-03 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Development of a small-molecule that enhances tripartite synapses for Alzheimers disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator LIN, CHIEN-LIANG GLENN Principal Investigator First Name CHIEN-LIANG Principal Investigator Last Name LIN Awardee Organization OHIO STATE UNIVERSITY Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $1,488,988 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
